Literature DB >> 25650561

Teaching children who use augmentative and alternative communication to ask inverted yes/no questions using aided modeling.

Jennifer Kent-Walsh, Cathy Binger, Carolyn Buchanan.   

Abstract

PURPOSE: This study investigated the effects of a direct intervention program involving aided modeling and the presentation of contrastive targets on the aided production of inverted yes/no questions and possible generalization to other sentence types by children using augmentative and alternative communication (AAC).
METHOD: A single-case, multiple-probe, experimental design across participants was used to evaluate the effects of the instructional program with 3 children who had motor speech disorders and used AAC (ages 4;10 [years;months], 6;2, and 4;9). The treatment involved aided modeling of treatment and contrastive targets through concentrated modeling and interactive play activities. Direct treatment outcomes were examined by measuring the accuracy of producing inverted yes/no questions and to be declaratives through probes.
RESULTS: All 3 participants showed a direct treatment effect, producing a greater number of inverted yes/no questions and to be declaratives within the probes following treatment compared with before treatment. All 3 participants evidenced some generalization to novel sentences.
CONCLUSIONS: Results provide initial evidence that instruction involving aided modeling with contrastive targets holds promise in targeting specific linguistic rules with children using AAC. Patterns of generalization may depend on participants' specific language deficits and acquisition patterns during intervention.

Entities:  

Mesh:

Year:  2015        PMID: 25650561     DOI: 10.1044/2015_AJSLP-14-0066

Source DB:  PubMed          Journal:  Am J Speech Lang Pathol        ISSN: 1058-0360            Impact factor:   2.408


  8 in total

1.  Error patterns and revisions in the graphic symbol utterances of 3- and 4-year-old children who need augmentative and alternative communication.

Authors:  Cathy Binger; Kaethe Richter; Allyson Taylor; Emily K Williams; Ashley Willman
Journal:  Augment Altern Commun       Date:  2019-02-26       Impact factor: 2.214

2.  Early Sentence Productions of 3- and 4-Year-Old Children Who Use Augmentative and Alternative Communication.

Authors:  Cathy Binger; Jennifer Kent-Walsh; Marika King; Lindsay Mansfield
Journal:  J Speech Lang Hear Res       Date:  2017-07-12       Impact factor: 2.297

3.  Dynamic Assessment for 3- and 4-Year-Old Children Who Use Augmentative and Alternative Communication: Evaluating Expressive Syntax.

Authors:  Cathy Binger; Jennifer Kent-Walsh; Marika King
Journal:  J Speech Lang Hear Res       Date:  2017-07-12       Impact factor: 2.297

4.  Tracking Early Sentence-Building Progress in Graphic Symbol Communication.

Authors:  Cathy Binger; Jennifer Kent-Walsh; Nancy Harrington; Quinn C Hollerbach
Journal:  Lang Speech Hear Serv Sch       Date:  2020-04-07       Impact factor: 2.983

5.  The emergence of clause construction in children who use speech generating devices.

Authors:  Gat Savaldi-Harussi; Lyle Lustigman; Gloria Soto
Journal:  Augment Altern Commun       Date:  2019-05-09       Impact factor: 2.214

6.  Language Sampling for Preschoolers With Severe Speech Impairments.

Authors:  Cathy Binger; Jamie Ragsdale; Aimee Bustos
Journal:  Am J Speech Lang Pathol       Date:  2016-11-01       Impact factor: 2.408

7.  An Initial Investigation Into the Feasibility of the Communication Matrix Professional Development Program for Educational Professionals Working With Students With Complex Communication Needs.

Authors:  Emily D Quinn; Alexandria Cook; Jack Wiedrick; Charity Rowland
Journal:  Lang Speech Hear Serv Sch       Date:  2021-10-08       Impact factor: 2.215

8.  Teaching Preschoolers With Down Syndrome Using Augmentative and Alternative Communication Modeling During Small Group Dialogic Reading.

Authors:  Emily D Quinn; Ann P Kaiser; Jennifer R Ledford
Journal:  Am J Speech Lang Pathol       Date:  2019-11-07       Impact factor: 2.408

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.